The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

SNN Q&A with Caladrius Biosciences, Inc. - Cell Therapy Service Provider and Developing Platform Technology for Immuno-Oncology

SNN Q&A with Caladrius Biosciences, Inc. (NASDAQ: CLBS)

Share With

Tuesday, December 08, 2015

   

© 2017 Stock News Now